Retroperitoneal fibrosis caused by treatment with pergolide in a patient with Parkinson's disease

Br J Urol. 1998 Jul;82(1):147. doi: 10.1046/j.1464-410x.1998.00603.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antiparkinson Agents / adverse effects*
  • Female
  • Humans
  • Pergolide / adverse effects*
  • Retroperitoneal Fibrosis / chemically induced*

Substances

  • Antiparkinson Agents
  • Pergolide